K
v
ire
.com
←
Back
Night
Docs
Library
Review
…
Author
Samuel A. Wells
also known as S A Wells, S Wells, S. A. WELLS
Southern Utah University · King's College London · Smithsonian Institution · University of North Carolina at Chapel Hill
About this author
Works
530
Cited by
24,723
h-index
72
i10
203
Top papers
Revised American Thyroid Association Guidelines for the Management of Medullary Thyroid Carcinoma
Samuel A. Wells, L. Sylvia, Henning Dralle, et al.
·
2015
·
Thyroid
↗ 2,362
OA
CONSENSUS: Guidelines for Diagnosis and Therapy of MEN Type 1 and Type 2
Maria Luisa Brandi, Robert F. Gagel, Alberto Angeli, et al.
·
2001
·
The Journal of Clinical Endocrinology & Metabolism
↗ 1,901
OA
Vandetanib in Patients With Locally Advanced or Metastatic Medullary Thyroid Cancer: A Randomized, Double-Blind Phase III Trial
Samuel A. Wells, Bruce G. Robinson, Robert F. Gagel, et al.
·
2011
·
Journal of Clinical Oncology
↗ 1,533
OA
Medullary Thyroid Cancer: Management Guidelines of the American Thyroid Association
Richard T. Kloos, Charis Eng, Douglas B. Evans, et al.
·
2009
·
Thyroid
↗ 1,352
Mutations in the RET proto-oncogene are associated with MEN 2A and FMTC
Helen Donis-Keller, Shenshen Dou, David Chi, et al.
·
1993
·
Human Molecular Genetics
↗ 1,303
Biologic and Clinical Perspectives on Thyroid Cancer
James A. Fagin, Samuel A. Wells
·
2016
·
New England Journal of Medicine
↗ 980
OA
Summary Statement from a Workshop on Asymptomatic Primary Hyperparathyroidism: A Perspective for the 21st Century
John P. Bilezikian, John T. Potts, Ghada El‐Hajj Fuleihan, et al.
·
2002
·
The Journal of Clinical Endocrinology & Metabolism
↗ 773
OA
Single missense mutation in the tyrosine kinasecatalytic domain of the RET protooncogene is associated with multiple endocrineneoplasia type 2B.
Katrin M. Carlson, Shuo‐Xing Dou, David Chi, et al.
·
1994
·
Proceedings of the National Academy of Sciences
↗ 598
OA
Vandetanib for the Treatment of Patients With Locally Advanced or Metastatic Hereditary Medullary Thyroid Cancer
Samuel A. Wells, Jessica E. Gosnell, Robert F. Gagel, et al.
·
2010
·
Journal of Clinical Oncology
↗ 516
OA
Predictive DNA Testing and Prophylactic Thyroidectomy in Patients at Risk for Multiple Endocrine Neoplasia Type 2A
Samuel A. Wells, Doina David, Koji Toshima, et al.
·
1994
·
Annals of Surgery
↗ 446
OA
Prophylactic Thyroidectomy in Multiple Endocrine Neoplasia Type 2A
Michael A. Skinner, Jeffrey Moley, William G. Dilley, et al.
·
2005
·
New England Journal of Medicine
↗ 378
OA
The Increase in Thyroid Cancer Incidence During the Last Four Decades Is Accompanied by a High Frequency of <i>BRAF</i> Mutations and a Sharp Increase in <i>RAS</i> Mutations
Chan Kwon Jung, Mark P. Little, Jay H. Lubin, et al.
·
2013
·
The Journal of Clinical Endocrinology & Metabolism
↗ 341
OA